Average Co-Inventor Count = 3.04
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (70 from 1,778 patents)
2. Other (10 from 832,912 patents)
3. High Point Pharmaceuticals, LLC (7 from 50 patents)
4. Vtv Therapeutics LLC (5 from 52 patents)
5. A/s Ferrosan (2 from 41 patents)
6. University of California (1 from 15,528 patents)
7. Eli Lilly and Company (1 from 4,449 patents)
8. Novo Nordiskals (1 from 10 patents)
9. Ziylo Limited (1 from 2 patents)
10. Novo Novdisk A/s (1 from 1 patent)
99 patents:
1. 12514822 - Oral dosing of GLP-1 compounds
2. 12239739 - Oral dosing of GLP-1 compounds
3. 12227528 - Glucose-sensitive albumin-binding derivatives
4. 11767332 - Glucose-sensitive albumin-binding derivatives
5. 11572398 - GLP-1 derivatives and uses thereof
6. 11541122 - Glucose sensitive insulins and uses thereof
7. 11420929 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
8. 11382957 - Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
9. 11186595 - Glucose-sensitive albumin-binding derivatives
10. 11033499 - Tablet formulation comprising a GLP-1 peptide and a delivery agent
11. 10960052 - Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid
12. 10947180 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
13. 10471066 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
14. 10278923 - Oral dosing of GLP-1 compounds
15. 10266577 - GLP-1 derivatives, and uses thereof